Discovery AI, the engine behind an integrated life sciences company.
One platform, one set of Australian laboratories, and three connected pillars that share the same engine, so the value of every discovery extends across the whole business.
What Discovery AI is.
Discovery AI is the digital and scientific backbone of the company. It brings AI led discovery, thermodynamic and off target analysis, synthesis ordering, manufacturing workflow and program management into one connected system. Researchers design candidates in the Discovery AI module, then order the material through the same system, with full traceability from a gene of interest to trial ready product. Nothing is rebuilt or revalidated as work moves from one stage to the next, because it never leaves the platform. Discovery AI is accessible through the Syngenis One platform.
Every program run through Discovery AI feeds data back into the engine. As more therapeutic candidates are evaluated, validated, or refined, the system's predictive accuracy improves — creating a compounding intelligence advantage that grows with every client program and every target explored. This is not a static tool; it is a continuously improving discovery engine.
Why an integrated platform beats a chain of suppliers.
Traditionally, a nucleic acid program is assembled from a chain of separate providers: one for target databases, another for design tools, another for synthesis, another for characterisation, another for clinical work. Every hand off adds time, cost, revalidation and intellectual property exposure. Discovery AI removes the hand offs. Discovery, manufacture and clinical delivery share one chain of custody, one quality framework and one accountable partner.
How a discovery moves through Syngenis.
Discover
Discovery AI identifies and ranks targets from the biology.
Design
It designs RNA and DNA candidates and calculates their biophysical properties.
Validate
Off target screening and in silico trial modelling reduce risk before the bench.
Order and make
Confirmed candidates are ordered through the Discovery AI system and synthesised in our own laboratories.
Advance
Our specialist CRO carries programs into regulated clinical work.
Scale
Research grade to GMP grade manufacturing supports growth, all on home soil.
Why integration matters.
- Speed. What took months of manual work across disconnected tools now happens in one guided workflow.
- Protection. Keeping discovery and manufacture together keeps intellectual property in one place, in Australia.
- Compliance. No repeated validation or regulatory rebuild every time work changes hands.
- Compounding value. Every program that runs through Discovery AI strengthens every other part of the platform.
Ready to work with an integrated life sciences company?
Talk to our team about your program, from candidate design to trial ready material.